Mikhail Blagosklonny is an accomplished scientist, physician, scholar, writer, and professor in medicine and oncology. He took his medical studies at First Pavlov State Medical University of St. Petersburg, where he obtained a Master’s Degree in Internal Medicine and a PhD in Experimental Medicine and Cardiology.
Mikhail began practicing as an associate professor of medicine in New York Medical College, Valhalla in 2002 and later was taken in by Ordway Research Institute as a senior scientist. On the 15th April, 2009, Blagosklonny got a coveted appointment as the Professor of Oncology in Roswell Park Cancer Institute. His research on cancer and its therapies, Biogerontology; mechanism of aging and advocacy on the use of Rapamyclin as a cancer and anti-aging drug to elongate life, are some of the remarkable work he has done in medicine. Read more about Mikhail at LinkedIn
Mikhail Blagosklonny talks of the possible role in aging where he outlines the correlation between a cellular system that control growth of cells, development and aging subject to dynamic external environment with varying factors such as nutrient availability, energy levels, growth factors and physiological stresses. He argues that it relays signals of these changes, from which a regulatory action in growth and metabolism is taken in all eukaryotic cells. Rapamycin has been proven to inhibit growth of cells and therefore can be used in cancer treatment to prevent growth or rejuvenation of cancer cells.
This renowned oncologist and scholar has brought forth more than 270 publication from his research work with over 2500 citations just to show the depth of his work and his passionate desire on ways to eradicate cancer cells.following this, he is a member of the editorial board of Cell Death and Differentiation, an associate editor of cancer Biology and therapy and the Editor in Chief of Oncotarget.
At Roswell Park Cancer Institute, Mikhail Blagosklonny currently holds the prestigious position of a professor of oncology where he continues to teach on cell growth and development. He also does his research while at the center and is continually writing more publications on the same.